D1989868261 - Zotero app not syncing with my online library

KathieBailey
Debug ID: D1989868261
My Zotero app is not syncing with my online library. I've remove tags and have let it open for a long period of time, but still no luck.
Can you help me with this?
  • KathieBailey
    I should add - that I know it is this computer. My other computer syncs with the online library
  • dstillman
    The creator name ‘[…]’ is too long to sync. Shorten the name and sync again.

    If you receive this message repeatedly for items saved from a particular site, you can report this issue in the Zotero Forums.
    You're getting an error about creators, not tags.
  • KathieBailey
    Yes. The tags was a previous issue. I am getting the message repeatedly, but I"m not sure which database is causing the problem. Is there a way to figure that out (I imported several).
  • dstillman
    edited March 20, 2023
    Click the Show Item button if there is one (I can’t remember) or search for the creator in the error message in All Fields & Tags mode.
  • KathieBailey
    it looks like the problem is coming from my psycinfo records that I exported from OVID.
  • dstillman
    edited March 25, 2023
    If you still have it, can you open the export file from Ovid in Notepad and paste in an example record that this is happening for? It would be a bug in their export, but we can see if there's anything we can do about it.
  • KathieBailey
    Yes. But the record is two long for a single post. So I’m posting in parts.
    30.
    TY - JOUR
    ID - 2021-17831-001
    DO - https://dx.doi.org/10.1016/j.yebeh.2020.107676
    T1 - Epilepsy: A bibliometric analysis (1968-2020) of the Instituto Nacional de Neurologia y Neurocirugia ''Manuel Velasco Suarez" in Mexico.
    A1 - Rubio, Carmen
    A1 - Luna, Rudy
    A1 - Ibarra-Velasco, Monserrat
    A1 - Lee, Angel
    AI - Rubio, Carmen; ORCID: https://orcid.org/0000-0002-4775-5043
    AI - Luna, Rudy; ORCID: https://orcid.org/0000-0001-5684-0306
    AI - Ibarra-Velasco, Monserrat; ORCID: https://orcid.org/0000-0001-6499-3636
    AI - Lee, Angel; ORCID: https://orcid.org/0000-0002-2301-3598
    A2 - Beghi, Carpio, Castaneda-Lopez, Cloix, de Boer, Dieguez-Campa, Dircio-Bautista, Escobedo-Rios, Fiest, Galvan, Ganesh, Gonzalez-Esquivel, Hauser, Hu, Iftikhar, Lopez, Lopez-Naranjo, Martinez, Martinez-Juarez, Medina, Mendez-Armenta, Muller, Nitrini, Ortega-Vazquez, Resendiz-Aparicio, Rubio, Rubio Donnadieu, Rubio Donnadieu, Ruiz-Coronel, San-Juan, Soriano Sanchez, Suzuki, Tanaka, Tellez-Zenteno, Vindrola, Vindrola, Vindrola, Vindrola, Wong
    Y1 - 2021//
    N2 - The Instituto Nacional de Neurologia y Neurocirugia "Manuel Velasco Suarez" (INNN) is one of the main institutions in Latin America treating epilepsy; and bibliometric analysis has an increasing role in analyzing the literature, acting as a Google Maps of medical research. We tracked the scientific output in Scopus and the impact of the institution from its foundation to July 2020 in the field of epilepsy. We roughly separated this group by clinical and experimental approach, identifying core journals, type of article, increase with time, and number of citations. A total of 228 papers, from a total of 3,034 produced by the INNN in that period, were found. Additionally, we identified that neurocysticercosis, pharmacology, genetics, and proteins involved in epilepsy were the most investigated topics. Also, there is a sustained growth in the number of papers per year since 1985. The number of authors per paper ranges from one to 15, and neuroscience journals are the preferred target of researchers, with a predilection for "Epilepsy and Behavior". (PsycInfo Database Record (c) 2023 APA, all rights reserved)
    KW - *Epilepsy
    KW - *Medical Sciences
    KW - *Scientific Communication
    M3 - Health & Mental Health Personnel Issues [3400]
    JF - Epilepsy & Behavior
    VL - 115
    CY - Netherlands
    PB - Elsevier Science
    PB - Netherlands
    SN - 1525-5050
    AD - Lee, Angel, dr_angel_lee@yahoo.de
    AD - Lee, Angel: dr_angel_lee@yahoo.de
    M1 - Beghi, E. (2020). The epidemiology of epilepsy. Neuroepidemiology, 54(Suppl. 2), 185-191 DOI:10.1159/000503831
    M1 - Carpio, A., Escobar, A., & Hauser, W.A. (1998). Cysticercosis and epilepsy: a critical review. Epilepsia, 39(10), 1025-1040 DOI:10.1111/j.1528-1157.1998.tb01287.x
    M1 - Castaneda-Lopez, G. (2005). 40 anos de vida a traves de una revista: el Instituto Nacional de Neurologia y Neurocirugia y su publicacion oficial. Arch Neurocien, 10(1).
    M1 - Cloix, J.F., & Hevor, T. (2009). Epilepsy, regulation of brain energy metabolism and neurotransmission. Curr Med Chem, 16(7), 841-853 DOI:10.2174/092986709787549316
    M1 - de Boer, H.M. (2010). Epilepsy stigma: Moving from a global problem to global solutions. Seizure, 19(10), 630-636 DOI:10.1016/j.seizure.2010.10.0172010-25367-010
    M1 - Dieguez-Campa, C., Perez-Neri, I., Reyes-Teran, G., Flores-Apodaca, I.A., Castillo-Ledon-Pretelini, J., Mercado-Bautista, O., et al. (2020). research pandemic: a bibliometric analisis of publications on COVID-19 and their scientific impact during the first months. Archivos de Cardiologia de Mexico, 2020 DOI:10.24875/ACM.20000370
    M1 - Dircio-Bautista, M., Colin-Gonzalez, A.L., Aguilera, G., Maya-Lopez, M., Villeda-Hernandez, J., Galvan-Arzate, S., et al. (2018). The antiepileptic drug levetiracetam protects against quinolinic acid-induced toxicity in the rat striatum. Neurotox Res, 33(4), 837-845 DOI:10.1007/s12640-017-9836-4
    M1 - Escobedo-Rios, F., & Rubio-Donnadieu, F. (1973). Epidemiology of epilepsy. Gaceta Medica de Mexico, 105(2), 155-165.
    M1 - Fiest, K.M., Sauro, K.M., Wiebe, S., Patten, S.B., Kwon, C.-S., Dykeman, J., et al. (2017). Prevalence and incidence of epilepsy: a systematic review and meta-analysis of international studies. Neurology, 88(3), 296-303 DOI:10.1212/WNL.00000000000035092017-03086-013
    M1 - Galvan, L.C., Rios, N., Lansingh, V.C., Lee, A., Wu, L., & Lopez, E. (2018). Analysis of ophthalmological and vision-related publications in Latin America. Arq Bras Oftalmol, 81(1), 24-29 DOI:10.5935/0004-2749.20180007
    M1 - Ganesh, S., Delgado-Escueta, A.V., Suzuki, T., Francheschetti, S., Riggio, C., Avanzini, G., et al. (2002). Genotype-phenotype correlations for EPM2A mutations in Lafora's progressive myoclonus epilepsy: exon 1 mutations associate with an early-onset cognitive deficit subphenotype. Hum Mol Genet, 11(11), 1263-1271 DOI:10.1093/hmg/11.11.1263
    M1 - Gobierno de Mexico. https://www.gob.mx/insalud/acciones-y-programas/institutos-nacionales-de-salud-27376; 2019[accesed 16 October 2020].
    M1 - Gonzalez-Esquivel, D.F., Ortega-Gavilan, M., Alcantara-Lopez, G., & Jung-Cook, H. (2000). Plasma level monitoring of oxcarbazepine in epileptic patients. Arch Med Res, 31(2), 202-205 DOI:10.1016/S0188-4409(00)00056-4
    M1 - Hauser, W.A., & Beghi, E. (2008). First seizure definitions and worldwide incidence and mortality. Epilepsia, 49(Suppl. 1), 8-12 DOI:10.1111/j.1528-1167.2008.01443.x2008-00160-003
    M1 - Hu, X., Gao, W., Xu, M., & Fang, Q. (2013). Publications from China in epilepsia. Epilepsia, 54(11), 1851 DOI:10.1111/epi.12381
    M1 - Iftikhar, P.M., Ali, F., Faisaluddin, M., Khayyat, A., De Gouvia De Sa, M., & Rao, T. (2019). A bibliometric analysis of the top 30 most-cited articles in gestational diabetes mellitus literature (1946-2019) Published 2019 Feb 25. Cureus, 11(2), e4131 DOI:10.7759/cureus.4131
    M1 - INEGI. https://www.inegi.org.mx/temas/derechohabiencia/; 2015[accesed 19 October 2020].
    M1 - Ley de los Institutos Nacionales de Salud.http://www.diputados.gob.mx/LeyesBiblio/pdf/51_291119.pdf; 2019[accesed 19 October 2020].
    M1 - Lopez, T., Basaldella, E.I., Ojeda, M.L., Manjarrez, J., & Alexander-Katz, R. (2006). Encapsulation of valproic acid and sodic phenytoin in ordered mesoporous SiO2 solids for the treatment of temporal lobe epilepsy. Opt Mater, 29(1), 75-81 DOI:10.1016/j.optmat.2006.03.017
    M1 - Lopez-Naranjo, F., Castaneda-Lopez, C., Rojas-Oviedo, I., Altagracia-Martinez, M., Krazov-Jinich, J., Manjarrez-Marmolejo, J., et al. (2003). Anticonvulsant activity of dapsone analogs. Arch Med Res, 34(4), 269-272 DOI:10.1016/S0188-4409(03)00045-6
    M1 - Martinez, A., Fernandez-Mas, R., Valdes-Cruz, A., Magdaleno-Madrigal, V., & Fernandez-Guardiola, A. (2006). Cortical mapping showing the effect on enkephalins in an epileptic focus. Salud Mental, 28(1), 18-27. https://www-scopus-com.pbidi.unam.mx:2443/record/display.uri?eid=2-s2.0-17344367803&origin=resultslist&sort=plf-f&src=s&st1=Cortical+mapping+showing+the+effect+of+enkephalins+in+an+epileptic+focus&st2=&sid=b0ba5706244b2452ea873342c1fc724f&sot=b&sdt=b&sl=87&s=TITLE-ABS-KEY(Cortical+mapping+showing+the+effect+of+enkephalins+in+an+epileptic+focus)&relpos=0&citeCnt=0&searchTerm=2005-04108-003
    M1 - Martinez-Juarez, I.E., Alonso, M.E., Medina, M.T., Duron, R.M., Bailey, J.N., Lopez-Ruiz, M., et al. (2006). Juvenile myoclonic epilepsy subsyndromes: family studies and long-term follow-up. Brain, 129(Pt 5), 1269-1280 DOI:10.1093/brain/awl0482006-05635-013
    M1 - Medina, M.T., Rosas, E., Rubio-Donnadieu, F., & Sotelo, J. (1990). Neurocysticercosis as the main cause of late-onset epilepsy in Mexico. Arch Intern Med. 150(2), 325-327.
  • KathieBailey
    M1 - Mendez-Armenta, M., Nava-Ruiz, C., Juarez-Rebollar, D., Rodriguez-Martinez, E., & Gomez, P.Y. (2014). Oxidative stress associated with neuronal apoptosis in experimental models of epilepsy. Oxid Med Cell Longev, 2014 DOI:10.1155/2014/293689
    M1 - Muller, S.M., Mueller, G.F., Navarini, A.A., & Brandt, O. (2020). National publication productivity during the COVID-19 pandemic-a preliminary exploratory analysis of the 30 countries most affected Published 2020 Sep 5. Biology (Basel), 9(9), E271 DOI:10.3390/biology9090271
    M1 - Nitrini, R. (2006). The scientific production of Brazilian neurologists: 1995-2004. Arq Neuropsiquiatr, 64(2B), 538-542 DOI:10.1590/s0004-282x20060003000372006-09929-037
    M1 - Ortega-Vazquez, A., Fricke-Galindo, I., Dorado, P., Jung-Cook, H., Martinez-Juarez, I.E., Monroy-Jaramillo, N., et al. (2020). Influence of genetic variants and antiepileptic drug co-treatment on lamotrigine plasma concentration in Mexican Mestizo patients with epilepsy [published online ahead of print, 2020 Jun 2]. Pharmacogenomics J DOI:10.1038/s41397-020-0173-2
    M1 - Resendiz-Aparicio, J.C. (2019). Guias clinicas del Programa Prioritario de Epilepsia del Sector Salud, Mexico. Revista Mexicana de Neurociencia, 20(2).M1 - Rodriguez, Reyes, & Yasmin. (2010). Doctor Jose Humberto Mateos Gomez nota bibliografica. Arch Neurocien (Mexico), 15(4), 279-280. https://www.medigraphic.com/pdfs/arcneu/ane-2010/ane104l.pdf.
    M1 - Rubio, C., Taddei, E., Acosta, J., Custodio, V., & Paz, C. (2020). Neuronal excitability in epileptogenic zones regulated by the Wnt/B-catenin pathway. CNS Neurol Disord Drug Targets, 19(1), 2-11 DOI:10.2174/1871527319666200120143133
    M1 - Rubio DonnadieuF, ResendizJC. ?Que es PPE?2019. http://www.epilepsiamexico.gob.mx/que-es.html [accessed 9 November 2020].M1 - Rubio Donnadieu, F., Resendiz, J.C., Senties, H., Ramos Peek, J., Salgado, P., Alonso Vanegas, M., et al. (2007). Programa Prioritario de Epilepsia del Sector Salud. Capitulo 2. Epidemiologia de la epilepsia. Epilepsia, 9-12.
    M1 - Ruiz-Coronel, A., Andrade, J.L.J., & Carrillo-Calvet, H. (2020). National Cancer Institute scientific production scientometric analysis. Analisis cienciometrico de la produccion cientifica del Instituto Nacional de Cancerologia. Gac Med Mex, 156(1), 4-10 DOI:10.24875/GMM.19005103
    M1 - San-Juan, D., Alvarado-Leon, S., Barraza-Diaz, J., Davila-Avila, N.M., Ruiz, A.H., & Anschel, D.J. (2015). Prevalence of epilepsy, beliefs and attitudes in a rural community in Mexico: A door-to-door survey. Epilepsy Behav, 46, 140-143 DOI:10.1016/j.yebeh.2015.03.0252015-16668-001
    M1 - Soriano Sanchez, J.A., Soriano Solis, S., Soto Garcia, M.E., & Romero Rangel, J.A.I. (2020). Scientific contributions of the Mexican Association of Spine Surgeons (Asociacion Mexicana de Cirujanos de Columna-AMCICO) to the global medical literature: a 21-year systematic review. World Neurosurg, 138, e223-e240 DOI:10.1016/j.wneu.2020.02.090
    M1 - Suzuki, T., Delgado-Escueta, A.V., Aguan, K., Alonso, M.E., Shi, J., Hara, Y., et al. (2004). Mutations in EFHC1 cause juvenile myoclonic epilepsy. Nat Genet, 36(8), 842-849 DOI:10.1038/ng1393
    M1 - Tanaka, M., Olsen, R.W., Medina, M.T., Schwartz, E., Alonso, M.E., Duron, R.M., et al. (2008). Hyperglycosylation and reduced GABA currents of mutated GABRB3 polypeptide in remitting childhood absence epilepsy. Am J Hum Genet, 82(6), 1249-1261 DOI:10.1016/j.ajhg.2008.04.020
    M1 - Tellez-Zenteno, J.F., Dhar, R., & Wiebe, S. (2005). Long-term seizure outcomes following epilepsy surgery: a systematic review and meta-analysis. Brain, 128(Pt 5), 1188-1198 DOI:10.1093/brain/awh4492005-11530-012
    M1 - The World Bank. GDF. 2018. http://datatopics.worldbank.org/world-development-indicators/[accesed 9 November 2020].
    M1 - Vindrola, O., Asai, M., Zubieta, M., & Linares, G. (1983). Brain content of immunoreactive [Leu5]enkephalin and [Met5]enkephalin after pentylenetetrazol-induced convulsions. Eur J Pharmacol, 90(1), 85-89 DOI:10.1016/0014-2999(83)90216-9
    M1 - Vindrola, O., Asai, M., Zubieta, M., Talavera, E., Rodriguez, E., & Linares, G. (1984). Pentylenetetrazol kindling produces a long-lasting elevation of IR-Met-enkephalin but not IR-Leu-enkephalin in rat brain. Brain Res, 297(1), 121-125 DOI:10.1016/0006-8993(84)90548-1
    M1 - Vindrola, O., Briones, R., Asai, M., & Fernandez-Guardiola, A. (1981). Brain content of leu5- and met5-enkephalin changes independently during the development of kindling in the rat. Neurosci Lett, 26(2), 125-130 DOI:10.1016/0304-3940(81)90337-2
    M1 - Vindrola, O., Briones, R., Asai, M., & Fernandez-Guardiola, A. (1981). Amygdaloid kindling enhances the enkephalin content in the rat brain. Neurosci Lett, 21(1), 39-43 DOI:10.1016/0304-3940(81)90054-9
    M1 - Wong, V.S.S., Stevenson, M., Mott, J., & Sahaya, K. (2019). Seizure and epilepsy publication in nonneurology journals. Epilepsy Behav, 93, 7-11 DOI:10.1016/j.yebeh.2019.01.0322019-24836-002
    DO - https://dx.doi.org/10.1016/j.yebeh.2020.107676
    L2 - http://ovidsp.ovid.com/ovidweb.cgi?T=JS&PAGE=reference&D=psyc19&NEWS=N&AN=2021-17831-001
    NL - Epilepsy Behav
    LA - English
    ER -

    Link to the Ovid Full Text or citation: https://login.ezproxy.library.ualberta.ca/login?url=http://ovidsp.ovid.com/ovidweb.cgi?T=JS&CSC=Y&NEWS=N&PAGE=fulltext&D=psyc19&AN=2021-17831-001Link to the External Link Resolver: https://resolver.library.ualberta.ca/resolver?sid=OVID:psycdb&amp;id=pmid:&amp;id=doi:10.1016/j.yebeh.2020.107676&amp;issn=1525-5050&amp;isbn=&amp;volume=115&amp;issue=&amp;spage=&amp;pages=&amp;date=2021&amp;title=Epilepsy+&+Behavior&amp;atitle=Epilepsy:+A+bibliometric+analysis+(1968-2020)+of+the+Instituto+Nacional+de+Neurologia+y+Neurocirugia+''Manuel+Velasco+Suarez"+in+Mexico.&amp;aulast=Rubio&amp;pid=<author>Rubio,+Carmen,Luna,+Rudy,Ibarra-Velasco,+Monserrat,Lee,+Angel</author><AN>2021-17831-001</AN><DT>Journal+Article</DT>
  • dstillman
    edited March 26, 2023
    OK, so Ovid is putting the last names of the authors of all of the paper's references into an A2 tag, which is generally used for editors. That's why you're getting a long Editor field with all of those names.

    So I'm afraid this is an example of why the current behavior is as it is. This is just an error in the import data. And the simple solutions aren't great:

    1) We could check for multiple commas and automatically turn these into separate Editor fields, but while that wouldn't block syncing, the data would still be wrong, you'd get incorrect references with erroneous editors, and it would be much more annoying to fix, since you'd have to delete 39 extra creator rows instead of 1.

    2) We could automatically truncate the field at 255 characters (the current sync limit), but then if these were valid authors or editors, we'd be throwing away data instead of letting you fix it (e.g., by copying to a text editor, adding newlines, and repasting).

    3) We could allow syncing of long (>255-character), obviously incorrect creator fields, but that would just propagate bad data and potentially performance problems to other synced devices and the web library, for data that needs to be corrected anyway. And there has to be some configured limit when storing data in a database.

    Probably the best option would be (4), dealing with this via batch-editing functionality, with a way to select all of these items and delete the Editor field for all of them. Batch editing is planned, but it will take some work to make a usable UI for things like this. We'll see what we can do there for a future version.

    For now, your best option is probably to delete all these items (sorting by Date Added if necessary) and use a text editor to delete all the A2 fields in the file in batch, and then repeat the import.

    Also note that you shouldn't get this when using the Save to Zotero button, only when exporting raw RIS from the site.
  • dstillman
    @KathieBailey: Actually, I provided some code to deal with this recently. You can select all the affected items and run this code from Tools → Developer → Run JavaScript to delete all the invalid creators:

    https://forums.zotero.org/discussion/comment/427614/#Comment_427614
Sign In or Register to comment.